Shah Trading Overseas Pvt. Ltd., a leading global active pharmaceutical ingredients (APIs), intermediates and nutraceuticals marketing major in the country, is stepping up its focus on pharma packing products going by the promising opportunities for growth in China. It has also the South East Asian region on its radar to expand operations.

The company has three offices in China at Hangzhou, Jinan, Shijiazhuang. While China is the only country as of now with which Shah TC is engaged with, it has plans to expand to South East Asian region where it has identified Indonesia, Japan, Korea among others to trade with customers in the pharma and nutraceutical space.

“We have been trading in China for Intermediates and APIs. But now we have also commenced trading in pharma packing products because of the  potential possibilities,” Nitin Talwar, senior manager, projects, Shah TC Overseas told Pharmabiz.

API’s, Intermediates and now the demand for the pharma packing products are on an upswing making China as the biggest producer of pharmaceuticals products. China market is large with growth driven by pricing and product quality. The country has become the workshop for the world and despite the global economic gloom it still continues to attract global players, he added.

The company is participating at the CPhI China which is being held between June 26-28, 2012 at Shanghai. It is looking for pharma packing products, APIs and intermediates for which it is confident of the quality but is looking for competitive pricing.

China is highly volatile market and it has around 3,500 drug companies. It has well established  pharma industry structure which has helped to evolve itself as the one of the largest pharmaceutical producers in the world catering to the requirements of regulated markets of US and European Union. Investment conditions in China improved due to the vast consumer demand for pharmaceuticals, lower labour costs and the changes in economic reform which attract us to invest in this country, he said.

“The New Delhi based Shah TC Overseas with a presence in China has over 200 suppliers with various quality certifications. We hold a strong competitive position with our portfolio of products, competitive pricing and timely assured deliveries. Its API range covers from aceclofanec IP, acyclovir USP/IP, albendazole CP, alfuzosin HCL to nevirapine, norfloxacin and zidovudine. We are also helping different Chinese companies with legal support in India for their products and will really continue to grow our base here,” said Talwar.